- Home
- UNCY vs SUUN Comparison
UNCY vs SUUN Comparison
Compare UNCY & SUUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- SUUN
- Stock Information
- Founded
- UNCY 2016
- SUUN 2013
- Country
- UNCY United States
- SUUN Canada
- Employees
- UNCY N/A
- SUUN N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- SUUN
- Sector
- UNCY Health Care
- SUUN
- Exchange
- UNCY Nasdaq
- SUUN Nasdaq
- Market Cap
- UNCY 71.8M
- SUUN 75.1M
- IPO Year
- UNCY 2021
- SUUN N/A
- Fundamental
- Price
- UNCY $0.64
- SUUN $2.05
- Analyst Decision
- UNCY Strong Buy
- SUUN Strong Buy
- Analyst Count
- UNCY 3
- SUUN 1
- Target Price
- UNCY $5.50
- SUUN $6.00
- AVG Volume (30 Days)
- UNCY 510.7K
- SUUN 134.5K
- Earning Date
- UNCY 05-16-2025
- SUUN 05-19-2025
- Dividend Yield
- UNCY N/A
- SUUN N/A
- EPS Growth
- UNCY N/A
- SUUN N/A
- EPS
- UNCY N/A
- SUUN N/A
- Revenue
- UNCY N/A
- SUUN $36,247,013.00
- Revenue This Year
- UNCY N/A
- SUUN $15.42
- Revenue Next Year
- UNCY $1,502.84
- SUUN $62.53
- P/E Ratio
- UNCY N/A
- SUUN N/A
- Revenue Growth
- UNCY N/A
- SUUN 43.76
- 52 Week Low
- UNCY $0.20
- SUUN $1.95
- 52 Week High
- UNCY $1.16
- SUUN $6.87
- Technical
- Relative Strength Index (RSI)
- UNCY 54.73
- SUUN 34.40
- Support Level
- UNCY $0.59
- SUUN $1.96
- Resistance Level
- UNCY $0.66
- SUUN $2.36
- Average True Range (ATR)
- UNCY 0.03
- SUUN 0.15
- MACD
- UNCY -0.00
- SUUN 0.03
- Stochastic Oscillator
- UNCY 57.75
- SUUN 22.50
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer and asset operator based in Canada and the United States. It is engaged in the development and operation of solar photovoltaic power generation projects in the province of Ontario and the state of New York. The company operates in two principal geographical areas - Canada and United States with a substantial portion of its overall revenue being generated from United States.